Heteroclitin D

CAS No. 140369-76-2

Heteroclitin D( —— )

Catalog No. M18001 CAS No. 140369-76-2

Heteroclitin D can inhibit L-type calcium channels and might be a valuable antitumor promoter or chemopreventor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 336 In Stock
10MG 489 In Stock
25MG 791 In Stock
50MG 1062 In Stock
100MG 1422 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Heteroclitin D
  • Note
    Research use only, not for human use.
  • Brief Description
    Heteroclitin D can inhibit L-type calcium channels and might be a valuable antitumor promoter or chemopreventor.
  • Description
    Heteroclitin D can inhibit L-type calcium channels. Heteroclitin D might be a valuable antitumor promoter or chemopreventor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    L-type calcium channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    140369-76-2
  • Formula Weight
    482.52
  • Molecular Formula
    C27H30O8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (103.62 mM)
  • SMILES
    CC=C(C)C(=O)OC1C(C(CC2=CC(=C(C(=O)C23COC4=C3C1=CC5=C4OCO5)OC)OC)C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DB722

    DB722 is a furamidine analogues with DNA binding activity. DB722 shows antiproliferative activity.

  • Cytidine 5'-diphosph...

    Cytidine 5'-diphosphate trisodium salt can produce Cytidine triphosphate for synthesis of DNA and RNA through the transfer of phosphoryl group from ATP to cytidine monophosphate (CMP) catalyzed by uridine monophosphate kinase (UMPK).

  • Gracillin

    Gracillin can induce cell cycle arrest, oxidative stress, and apoptosis in HL60 cells, and has the potential to be developed as an antitumor agent.